文献速递乳腺CTMRUS乳腺X线

乳腺X线摄影、数字乳腺断层合成、自动乳腺超声与磁共振成像在新辅助化疗后残余肿瘤评估中的比较

Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
PubMed 文献 · Eur J Radiol · 2018-10-02

纳入51例II-III期乳腺癌患者,于2015年3月至2016年12月接受新辅助化疗,比较MG、DBT、ABUS与MRI测量残余肿瘤最长径与病理大小的相关性及预测病理完全缓解的效能。MRI与病理相关性最佳(ICC=0.83),DBT次之(ICC=0.63),MG和ABUS分别为ICC=0.56和0.55。预测pCR的AUC:MRI 0.92、DBT 0.84、MG 0.72、ABUS 0.75。

要点

  • MRI测量残余肿瘤大小与病理相关性最佳(ICC=0.83),优于DBT(0.63)、MG(0.56)和ABUS(0.55)。
  • 预测pCR的AUC:MRI 0.92、DBT 0.84、ABUS 0.75、MG 0.72。
  • MRI与病理大小差异与DBT无统计学差异(p=0.5727),与MG和ABUS差异有统计学意义。

核心结论

  • MRI和DBT较MG和ABUS能更准确评估新辅助化疗后残余肿瘤大小,且在预测病理完全缓解方面优于MG和ABUS。

研究设计与样本

  • 单中心研究,纳入51例II-III期乳腺癌患者,于2015年3月至2016年12月接受新辅助化疗,比较MG、DBT、ABUS和MRI测量的残余肿瘤最长径与病理肿瘤大小,采用组内相关系数(ICC)和边际同质性检验进行统计分析,并用ROC分析评估预测pCR的诊断效能。

关键影像表现/征象

  • MRI测量的残余肿瘤最长径与病理大小相关性好(ICC=0.83),显著优于MG(ICC=0.56)、DBT(ICC=0.63)和ABUS(ICC=0.55)。
  • MRI与病理大小差异与DBT无统计学差异(p=0.5727),但与MG(p=0.0231)和ABUS(p=0.0039)差异有统计学意义。

诊断标准与关键数值

  • 预测pCR的AUC:MRI 0.92、DBT 0.84、MG 0.72、ABUS 0.75;以MRI为参考时,DBT p=0.3749、MG p=0.0972、ABUS p=0.0596。

临床应用与阅片要点

  • MRI测量残余肿瘤大小与病理相关性最佳(ICC=0.83),DBT次之(ICC=0.63),MG和ABUS分别为ICC=0.56和0.55。
  • 预测pCR的AUC:MRI 0.92、DBT 0.84、ABUS 0.75、MG 0.72;以MRI为参考时DBT p=0.3749、MG p=0.0972、ABUS p=0.0596。
  • MRI与病理大小差异与DBT无统计学差异(p=0.5727),与MG(p=0.0231)和ABUS(p=0.0039)差异有统计学意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: To compare the accuracy of mammography (MG), digital breast tomosynthesis (DBT), automated breast ultrasound (ABUS) and magnetic resonance imaging (MRI) for the assessment of residual tumor extent in breast cancer after neoadjuvant chemotherapy (NAC).

METHODS: Fifty-one stage II-III breast cancer undergoing NAC were enrolled from March 2015 to December 2016. The longest diameter of residual tumor measured with MG, DBT, ABUS and MRI was compared with the pathologic tumor size. Statistical analysis was performed using intraclass correlation coefficients (ICC) and marginal homogeneity test. Receiver operating characteristics (ROC) analysis was used to evaluate the diagnostic performance for predicting pathologic complete response (pCR).

RESULTS: MRI size correlated well with pathology (ICC = 0.83), significantly better than MG, DBT and ABUS size (ICC = 0.56, ICC = 0.63 and ICC = 0.55, respectively). The discrepancy between MRI and pathology was statistical different from that of MG and ABUS (p = 0.0231 and 0.0039, respectively), but not different from that of DBT (p = 0.5727). For predicting pCR, MRI and DBT had a better performance compared to MG and US (area under the ROC curve: 0.92, 0.84, 0.72, 0.75, respectively; p = 0.3749 for DBT, p = 0.0972 for MG and p = 0.0596 for ABUS, when MRI being reference).

CONCLUSIONS: MRI and DBT allow more accurate assessment of tumor size compared to pathology compared with MG and ABUS. MRI and DBT outperform MG and ABUS in the prediction of pathologic complete response.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Park J, Chae EY, Cha JH, et al. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy. Eur J Radiol. 2018. PMID: 30396666. doi:10.1016/j.ejrad.2018.09.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。